Health Care & Life Sciences » Pharmaceuticals | Korea United Pharm. Inc.

Korea United Pharm. Inc. | Balance Sheet

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
27,053
42,837
40,651
42,248
42,021
61,161
Total Accounts Receivable
38,431
41,129
45,541
45,090
51,473
51,559
Inventories
27,070
27,209
25,619
27,683
33,835
39,472
Other Current Assets
272
252
321
364
487
263
Total Current Assets
92,825
111,427
112,132
115,385
127,816
152,455
Net Property, Plant & Equipment
65,494
67,003
76,602
77,255
95,823
106,538
Total Investments and Advances
24,150
29,191
32,856
34,854
34,062
36,520
Long-Term Note Receivable
6,389
5,196
4,248
417
640
643
Intangible Assets
2,349
3,572
4,401
5,476
6,496
5,549
Other Assets
2,332
711
270
833
960
251
Total Assets
196,025
219,656
232,949
236,936
265,796
301,955
ST Debt & Current Portion LT Debt
5,507
4,990
14,480
10,645
18,178
Accounts Payable
6,693
4,995
6,775
6,099
6,829
Income Tax Payable
710
3,901
1,089
4,517
2,989
Other Current Liabilities
13,750
14,539
16,329
18,376
22,164
Total Current Liabilities
26,659
28,425
38,674
39,637
50,160
Long-Term Debt
18,307
19,779
13,392
10,572
7,000
Provision for Risks & Charges
2,145
1,815
1,564
1,561
1,743
Deferred Taxes
4,223
3,573
2,935
2,138
1,470
Other Liabilities
480
951
1,114
1,250
1,900
Total Liabilities
54,299
57,097
60,119
57,874
62,272
Common Equity (Total)
141,430
161,828
171,991
177,387
201,682
Total Shareholders' Equity
141,430
161,828
171,991
177,387
201,682
Total Equity
141,437
161,835
171,991
177,387
201,682
Liabilities & Shareholders' Equity
196,025
219,656
232,949
236,936
265,796
Accumulated Minority Interest
7
7
-
-
-
Non-Equity Reserves
288
724
839
1,675
1,843

About Korea United Pharm.

View Profile
Address
25-23 Nojanggongdan-gil
Sejong SE 30011
Korea, Republic Of
Employees -
Website http://www.kup.co.kr
Updated 07/08/2019
Korea United Pharm, Inc. engages in the manufacture and distribution of pharmaceuticals and healthcare products. Its products include medicines for gastrointestinal and blood circulation systems, pain killers, and antibiotics. The company was founded on December 3, 1987 and is headquartered in Sejong, South Korea.